Invesco Perpetual High Income Income Units 
HL comment
Our view on this Fund
The tough economic outlook is not a surprise to Neil Woodford, who has positioned the portfolio defensively for some time. However, he believes there are certain companies with sustainable dividends and earnings that can still thrive in this environment. These include pharmaceutical companies such as GlaxoSmithKline and AstraZeneca, and tobacco companies such as BAT and Reynolds American, which have been positive for performance recently against an uncertain economic backdrop.
14-11-2011
Information from the fund manager
Simplified prospectus/Key Investor Information
Document
Please note: The information in this box has been provided by, and is issued by, the fund manager and not Hargreaves Lansdown. Hargreaves Lansdown accepts no liability for the reliability or accuracy of the data provided by third parties.
HL sector comment: UK Equity Income
Our view on this sector
Many equity income stalwarts have performed admirably during the stock market turmoil of summer and autumn 2011. Pharmaceutical and telecommunication companies are two areas that have consistently paid high dividends and their valuations remain undemanding. In addition, the resumption of BP's dividend in 2011 helped boost the sector. This remains a competitive sector and investors have rich pickings with excellent fund managers who have managed money through many different economic cycles.
13-12-2011